Acquisition by Tomsche David Scott of 606 shares of ImmuCell at 7.75 subject to Rule 16b-3

ICCC Stock  USD 5.44  0.04  0.74%   
About 52% of ImmuCell's shareholders are presently thinking to get in. The analysis of overall sentiment of trading ImmuCell stock suggests that some investors are interested at this time. The current market sentiment, together with ImmuCell's historical and current headlines, can help investors time the market. In addition, many technical investors use ImmuCell stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by ImmuCell Director. Grant, award or other acquisition pursuant to Rule 16b-3

Read at macroaxis.com
Acquisition of 606 common stock, $0.10 per value per share at 7.75 of ImmuCell by Tomsche David Scott on 28th of October 2024. This event was filed by ImmuCell with SEC on 2022-09-12. Statement of changes in beneficial ownership - SEC Form 4

ImmuCell Fundamental Analysis

We analyze ImmuCell's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ImmuCell using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ImmuCell based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Profit Margin

Profit Margin Comparative Analysis

ImmuCell is currently under evaluation in profit margin category among its peers. Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.

ImmuCell Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ImmuCell stock to make a market-neutral strategy. Peer analysis of ImmuCell could also be used in its relative valuation, which is a method of valuing ImmuCell by comparing valuation metrics with similar companies.

Peers

ImmuCell Related Equities

TPSTTempest Therapeutics   5.56   
0%
58.0%
LCTXLineage Cell   5.00   
0%
52.0%
HCWBHCW Biologics   3.85   
0%
40.0%
ANEBAnebulo Pharmaceuticals   3.25   
0%
34.0%
CVKDCadrenal Therapeutics,   2.64   
0%
27.0%
MNOVMediciNova   1.49   
0%
15.0%
FENCFennec Pharmaceuticals   1.24   
0%
13.0%
ACOGFAlpha Cognition   0.94   
0%
9.0%
RZLTRezolute   0.77   
0%
8.0%
LIPOLipella Pharmaceuticals   0.37   
0%
3.0%
XOMAOXOMA   0.12   
0%
1.0%
TRGNFTransgene   0.00   
0%
0%
ONTTFOxford Nanopore   1.09   
11.0%
0%
PTIXProtagenic Therapeutics   9.52   
100.0%
0%

Complementary Tools for ImmuCell Stock analysis

When running ImmuCell's price analysis, check to measure ImmuCell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ImmuCell is operating at the current time. Most of ImmuCell's value examination focuses on studying past and present price action to predict the probability of ImmuCell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ImmuCell's price. Additionally, you may evaluate how the addition of ImmuCell to your portfolios can decrease your overall portfolio volatility.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Commodity Directory
Find actively traded commodities issued by global exchanges